UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of CDK9 Inhibition as a Sensitizer to Radiation in Esophageal Adenocarcinoma: in Vitro and in Vivo Efficacy Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1027-S1027

Veeranki, Omkara L

2017

Volltextzugriff (PDF)

Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention

British journal of nutrition, 2013-01, Vol.109 (1), p.25-32

2013

Volltextzugriff (PDF)

Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer

Current pharmacology reports, 2015-08, Vol.1 (4), p.272-282

2015

Volltextzugriff (PDF)

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Clinical cancer research, 2021-01, Vol.27 (1), p.120-130

2021

Volltextzugriff (PDF)

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

Therapeutic advances in medical oncology, 2019-07, Vol.11, p.1758835919864850

2019

Volltextzugriff (PDF)

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006533

2023

Volltextzugriff (PDF)

A novel patient derived orthotopic xenograft model of gastro-esophageal junction cancer: Key platform for translational discoveries

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.64-64

Veeranki, Omkara Lakshmi

2019

Volltextzugriff (PDF)

Tu1986 - Role of CDK9 Inhibition as a Sensitizer to Radiation in Esophageal Adenocarcinoma: in Vitro and in Vivo Efficacy Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S1027-S1027

Veeranki, Omkara L.

2017

Volltextzugriff (PDF)

First person – Omkara Lakshmi Veeranki

Disease models & mechanisms, 2019-12, Vol.12 (12)

2019

Volltextzugriff (PDF)

A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries

Disease models & mechanisms, 2019-12, Vol.12 (12)

2019

Volltextzugriff (PDF)

Loss of IL-10 Decreases Mouse Postpubertal Mammary Gland Development in the Absence of Inflammation

Immunological investigations, 2012-07, Vol.41 (5), p.521-537

2012

Volltextzugriff (PDF)

Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3859-3859

2019

Volltextzugriff (PDF)

Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma

Oncotarget, 2017-04, Vol.8 (17), p.28696-28710

2017

Volltextzugriff (PDF)

Abstract B06: A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries

Cancer research (Chicago, Ill.), 2020-06, Vol.80 (11_Supplement), p.B06-B06

2020

Volltextzugriff (PDF)

Abstract 3815: Cyclin-dependent kinase 9: a potential therapeutic target for esophageal adenocarcinoma

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3815-3815

2016

Volltextzugriff (PDF)

Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma

Oncotarget, 2019-07, Vol.10 (45), p.4703-4718

2019

Volltextzugriff (PDF)

Abstract 5843: Role of CDK9 inhibition as a sensitizer to radiation in esophageal adenocarcinoma: In vitro and in vivo efficacy study

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5843-5843

2017

Volltextzugriff (PDF)

Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target

European journal of surgical oncology, 2018-03, Vol.44, p.S24-S24

2018

Volltextzugriff (PDF)

Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target

European journal of surgical oncology, 2017-11, Vol.43 (11), p.2222-2222

2017

Volltextzugriff (PDF)

Abstract 3274: Loss of interleukin 10 (IL-10) decreases mouse mammary gland development and lactogenic differentiation

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.3274-3274

2010

Volltextzugriff (PDF)

Evaluation of Sulforaphane as a Potential Bladder Cancer Chemopreventive Agent

Veeranki, Omkara Lakshmi M

2015

Volltextzugriff (PDF)

Anti-inflammatory cytokine IL-10 and mammary gland development

Maheshwararao, Veeranki Omkara Lakshmi

2010

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)
Dissertationen
(2)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of CDK9 Inhibition as a Sensitizer to Radiation in Esophageal Adenocarcinoma: in Vitro and in Vivo Efficacy Study

Organ-specific exposure and response to sulforaphane, a key chemopreventive ingredient in broccoli: implications for cancer prevention

Cruciferous Vegetables, Isothiocyanates, and Prevention of Bladder Cancer

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies

A novel patient derived orthotopic xenograft model of gastro-esophageal junction cancer: Key platform for translational discoveries

Tu1986 - Role of CDK9 Inhibition as a Sensitizer to Radiation in Esophageal Adenocarcinoma: in Vitro and in Vivo Efficacy Study

First person – Omkara Lakshmi Veeranki

A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries

Loss of IL-10 Decreases Mouse Postpubertal Mammary Gland Development in the Absence of Inflammation

Abstract 3859: Targeting CDK9 and MCL-1 by a New CDK9/p-TEFB Inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma

Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma

Abstract B06: A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries

Abstract 3815: Cyclin-dependent kinase 9: a potential therapeutic target for esophageal adenocarcinoma

Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma

Abstract 5843: Role of CDK9 inhibition as a sensitizer to radiation in esophageal adenocarcinoma: In vitro and in vivo efficacy study

Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target

Targeting cyclin-dependent kinase 9 enhances sensitization to ionizing radiation in esophageal adenocarcinoma and identifies AXL as a novel downstream target

Abstract 3274: Loss of interleukin 10 (IL-10) decreases mouse mammary gland development and lactogenic differentiation

Evaluation of Sulforaphane as a Potential Bladder Cancer Chemopreventive Agent

Anti-inflammatory cytokine IL-10 and mammary gland development

Suchergebnisse filtern